So can we analyse this a little.
Going off https://clinicaltrials.gov/ct2/show/NCT03573518 stating there are five doses, can we assume:
- Dose 1 is CBD.
- Dose 2 is BTX 1503 (CBD AND PERMETREX) ONCE daily.
- Dose 3 is BTX 1503 (CBD AND PERMETREX) TWICE daily.
- Dose 4 is PERMETREX
- Dose 5 is PLACEBO.
Therefore, according to previous poster, if PERMETREX (DOSE 4) works then shouldn't BTX 1503 (DOSE 1 OR 2), as it contains PERMETREX? Is his so called lead investigator mate saying that CBD on its own performed the worst? Or are my doses totally incorrect?
So can we analyse this a little. Going off...
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 36.5¢ | $2.548M | 6.766M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 96148 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 782479 | 9 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |